Found 28 matching trials
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial PHASE3 This is a randomized, controlled clinical trial based on prior exploratory ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I) PHASE2 The goal of this clinical trial is to evaluate whether a total neoadjuvant ...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II) PHASE2 Most rectal cancers are microsatellite stable (MSS) or mismatch repair-prof...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study PHASE2 This is a phase II open-label study to evaluate the efficacy and safety of ...
Show More Location
Xijing Hospital, Air Force Medical University
Learn More & Join Trial
Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer PHASE1 This is a open-label, single-arm study to investigate the safety and effica...
Show More Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer PHASE2 This phase II/III trial studies how well neoadjuvant short-course radiother...
Show More Location
Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
Learn More & Join Trial
SCRT Followed by CAPOX + Bev ยฑ PD-1 Inhibitor for TNT in LARC PHASE2 This study aims to evaluate the efficacy and safety of short-course radioth...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma PHASE3 This study is a multicenter, randomized, double-blind, standard-of-care con...
Show More Status
Active Not Recruiting
Location
Beijing cancer hospital
Learn More & Join Trial
Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial PHASE2 Most colorectal cancers are microsatellite stable (MSS) or mismatch repair-...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer PHASE3 Building on earlier exploratory work, this study further designs a multi-in...
Show More Location
The First Affiliated Hospital of Guangxi Medical University
Learn More & Join Trial